ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1408

When Damage and Disability Diverge: Unraveling Sex-Based Drivers of Axial Spondyloarthritis Burden

Claudia Marques1, Gustavo Resende2, Carla Saad3, Adriana Marinho4, Andressa Soares5, Beatriz Paiva6, Cleandro Pires7, Débora Rodrigues8, Glaucio Castro9, Guilherme Bulbol10, Jamile Carneiro11, Manuella Ochtrop12, José Mauro Fernandes13, Maria Bernadete Gavi14, Maria Eduarda Veiga3, Michel Yazbek15, Nara Cavalcanti16, Natalia Machado17, Olivio Malheiro18, Rafael Bassara Macedo19, Rejane Vieira20, Ricardo Lage18, Rita Menin21, Rywka Golebiovski22, Sandra Ribeiro10, Thauana Oliveira22, Valquiria Diniz14, Percival Sampaio-Barros23 and Marcelo Pinheiro24, 1Hospital das Clinicas - Universidade Federal de Pernambuco - UFPE, Recife, Pernambuco, Brazil, 2Hospital das Clinicas UFMG, Belo Horizonte, Brazil, 3Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, Sao Paulo, Brazil, 4Fundação Hospital do Acre - AC, Rio Branco, Brazil, 5Hospital Universitário da Universidade Federal de Santa Catarina (UFSC) - SC, Florianópolis, Brazil, 6Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Brazil, 7UNB, Brasilia, Distrito Federal, Brazil, 8Fundação Hospital do Acre - AC, Rio Branco, Acre, Brazil, 9Hospital Governador Celso Ramos (HCR) - SC, Florianópolis, Santa Catarina, Brazil, 10Faculdade de Medicina da Universidade Federal do Amazonas (UFAM) - AM, Manaus, Amazonas, Brazil, 11Hospital de Base do Distrito Federal (HBDF) - DF, Brasilia, Distrito Federal, Brazil, 12Hospital Universitário Pedro Ernesto / UERJ - RJ, Rio de Janeiro, Rio de Janeiro, Brazil, 13Universidade Federal do Maranhão (UFMA) - MA, São Luiz, Maranhao, Brazil, 14Universidade Federal do Espírito Santo (UFES) - ES, Vitória, Espirito Santo, Brazil, 15Universidade Estadual de Campinas (UNICAMP) - SP, Campinhas, Sao Paulo, Brazil, 16Hospital das Clínicas da Universidade Federal de Pernambuco (UFPE) - PE, Recife, Pernambuco, Brazil, 17Universidade Fedral do Paraná (UFPR) - PR, Curitiba, Parana, Brazil, 18Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG) - MG, Belo Horizonte, Minas Gerais, Brazil, 19Rheumatology Division, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil, 20Universidade Estadual do Ceará (UECE) - CE, Fortaleza, Ceara, Brazil, 21Faculdade de Medicina de São José do Rio Preto (FAMERP) - SP, São José do Rio Preto, Sao Paulo, Brazil, 22Escola Paulista de Medicina (EPM) - Universidade Federal de São Paulo (UNIFESP) - SP, São Paulo, Sao Paulo, Brazil, 23Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil, São Paulo, Brazil, 24UNIFESP/ EPM, São Paulo, São Paulo, Brazil

Meeting: ACR Convergence 2025

Keywords: Ankylosing spondylitis (AS), gender, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Sex differences in axial spondyloarthritis (axSpA) are well recognized, but their clinical consequences remain understudied in real-world settings. This study aimed to assess sex-based differences in demographic, clinical, functional, and treatment-related characteristics among patients with axSpA, and to explore sex-specific predictors of disease burden

Methods: Cross-sectional analysis of patients with axSpA enrolled in the Brazilian Registry of Spondyloarthritis (RBE), a multicenter, observational cohort involving 46 referral centers across Brazil. Eligible participants were adults diagnosed with SpA and classified according to ASAS criteria. Disease activity and impact were assessed using validated indices: BASDAI, ASDAS-CRP, BASFI, BASMI, ASQoL, and mSASSS. Sex-stratified multivariable linear regression models were developed to identify independent predictors of disease activity, function, mobility, and quality of life. Model assumptions and multicollinearity were evaluated, and results were expressed as unstandardized beta coefficients with 95% confidence intervals.

Results: A total of 828 patients were included: 568 (68.6%) males and 260 (31.4%) females, with a similar median age between groups (p = 0.351). Although HLA-B27 positivity has been more frequent in males (71.0% vs. 29.0%; p = 0.009), the family history of SpA was more frequently reported by females (26.2% vs. 17.2%; p = 0.002), as well as anxiety (18.6% vs. 9.6%; p < 0.001; OR 2.14), depression (18.2% vs. 5.8%; p < 0.001; OR 3.58), and fibromyalgia (23.0% vs. 5.8%; p < 0.001; OR 4.80). Figure 1 illustrates significantly higher scores of BASDAI, ASDAS-CRP, BASFI, and ASQoL in women, while men had worse BASMI. Correlation matrices showed stronger associations between patient-reported outcomes in women and a stronger mSASSS–BASMI correlation in men. Multivariable models revealed distinct sex-specific patterns. In women, functional limitation (BASFI) and patient global assessment were consistent predictors across outcomes. In men, disease burden was associated with root joint pain, enthesitis, comorbidities (fibromyalgia, depression), and work status. Complementary logistic regression identified fibromyalgia, depression, family history, and higher BASDAI as independent correlates of female sex, while HLA-B27 positivity, hip limitation, and higher BASMI were associated with male sex.

Conclusion: These findings highlight contrasting profiles of axSpA by sex: a predominantly functional and subjective burden in women, and a more structural axial damage and inflammatory phenotype in men. Tailored assessment strategies may improve disease evaluation and management in both groups.

Supporting image 1Figure 1. Sex-based comparison of disease activity, function, mobility, and quality of life in patients with axial spondyloarthritis


Disclosures: C. Marques: None; G. Resende: None; C. Saad: None; A. Marinho: None; A. Soares: None; B. Paiva: None; C. Pires: None; D. Rodrigues: None; G. Castro: None; G. Bulbol: None; J. Carneiro: None; M. Ochtrop: None; J. Fernandes: None; M. Gavi: None; M. Veiga: None; M. Yazbek: None; N. Cavalcanti: None; N. Machado: None; O. Malheiro: None; R. Bassara Macedo: None; R. Vieira: None; R. Lage: None; R. Menin: None; R. Golebiovski: None; S. Ribeiro: None; T. Oliveira: None; V. Diniz: None; P. Sampaio-Barros: None; M. Pinheiro: AbbVie/Abbott, 2, Johnson & Johnson, 2, UCB, 2.

To cite this abstract in AMA style:

Marques C, Resende G, Saad C, Marinho A, Soares A, Paiva B, Pires C, Rodrigues D, Castro G, Bulbol G, Carneiro J, Ochtrop M, Fernandes J, Gavi M, Veiga M, Yazbek M, Cavalcanti N, Machado N, Malheiro O, Bassara Macedo R, Vieira R, Lage R, Menin R, Golebiovski R, Ribeiro S, Oliveira T, Diniz V, Sampaio-Barros P, Pinheiro M. When Damage and Disability Diverge: Unraveling Sex-Based Drivers of Axial Spondyloarthritis Burden [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/when-damage-and-disability-diverge-unraveling-sex-based-drivers-of-axial-spondyloarthritis-burden/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/when-damage-and-disability-diverge-unraveling-sex-based-drivers-of-axial-spondyloarthritis-burden/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology